Articles tagged with Nmda Receptors
Researchers at Johns Hopkins Medicine have identified a new neurotransmitter, D-serine, which activates key nerve cells in the brain. This discovery could lead to the development of new stroke treatments by inhibiting NMDA receptor activity.
Researchers discovered a protein called yotiao, which anchors enzymes to NMDA receptors in neurons, controlling electrical impulses. This sophisticated control mechanism allows for precise and rapid signaling, enabling nerve cells to rapidly recover from activation.
Researchers at Johns Hopkins Medicine discovered a peptide that closes an NMDA glutamate receptor, potentially aiding the development of stroke treatment drugs. The peptide, known as Mag-1.5, can help regulate communication between nerve cells and may provide insights for potential new therapies.